Mild psoriasis aligns well with the patientreported outcome of patient acceptable symptom state (PASS), according to a study in the Journal of Dermatology. Researchers examined the association of PASS with the Psoriasis Area and Severity Index (PASI) and body surface area (BSA) affected by lesions among 198 patients with psoriasis. PASS was assessed by a binary question relating to the patient’s feeling that they have about their symptoms. Most patients with mild psoriasis considered their symptom state acceptable (71.4% and 76.3% based on the PASI and BSA, respectively). The likelihood of reporting an acceptable symptom state was lower in association with female sex and for patients with exposed skin involved (adjusted OR, 0.47 and 0.38, respectively). The thresholds for differentiating psoriasis patients in PASS were 3.85% and 2.85% for the PASI and BSA, respectively.
